Skip to content

Dianthus Therapeutics

US · DNTH #2155 by market cap Listed 1970
84.55 -0.28 -0.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 9 analysts

Buy
Avg price target 134.63 +59.2%
Price target rangecurrent 84.55
Low113.00
Avg134.63
High158.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Stifel -- Buy 133.00
2026-11-06 H.C. Wainwright -- Buy 158.00
2026-11-05 Wells Fargo -- Buy 135.00
2026-11-05 Wedbush -- Buy 122.00
2026-11-05 Stifel -- Buy 133.00
2026-11-05 J.P. Morgan -- Buy 135.00
2026-10-27 Roth MKM -- Buy 113.00
2026-10-26 Roth MKM -- Buy 113.00
2026-10-16 Wells Fargo -- Buy 135.00
2026-10-16 H.C. Wainwright -- Buy 158.00
2026-10-15 H.C. Wainwright -- Buy 158.00
2026-10-01 H.C. Wainwright -- Buy 158.00
2026-09-29 LifeSci Capital -- Buy 125.00
2026-09-24 J.P. Morgan -- Buy --
2026-09-18 William Blair -- Buy --
2026-09-11 J.P. Morgan -- Buy 135.00
2026-09-04 Citi -- Buy 156.00
2026-08-13 Stifel -- Buy 133.00
2026-08-10 Evercore -- Buy 134.00
2026-08-06 Truist Financial -- Buy 128.00
2026-08-06 Stifel -- Buy 133.00
2026-08-06 H.C. Wainwright -- Buy 158.00
2026-08-05 TD Cowen -- Buy 150.00
2026-08-05 Wells Fargo -- Buy 135.00
2026-08-05 Wedbush -- Buy 122.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:59:44 · For reference only, not investment advice and not tailored to your situation.

Dianthus Therapeutics discussion 0 comments

Add a comment